Lexicon Pharmaceuticals
LXRX
#6457
Rank
HK$5.65 B
Marketcap
HK$13.34
Share price
-0.87%
Change (1 day)
377.04%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -HK$1.48

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$1.49. In 2024 the company made an earnings per share (EPS) of -HK$5.01 an increase over its 2023 EPS that were of -HK$6.26.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$1.48-70.53%
2024-HK$5.01-20%
2023-HK$6.2631.15%
2022-HK$4.77-0%
2021-HK$4.7710.91%
2020-HK$4.30-145.08%
2019HK$9.55-206.09%
2018-HK$9.00-5.74%
2017-HK$9.55-10.95%
2016-HK$10.722640%
2015-HK$0.39-96.34%
2014-HK$10.68-2.53%
2013-HK$10.96-9.09%
2012-HK$12.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
HK$139.08-9,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$34.99-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$337.49-22,794.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-HK$46.49 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$18.71-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-HK$3.91 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$5.87 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$21.29-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-HK$600.39 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA